Summary
Retinoic acid is known to cause the myeloid differentiation and G1/0 cell cycle arrest of HL-60 cells in a process that requires mitogen-activated protein/extracellular signal regulated kinase (MEK)-dependent extracellular signal regulated kinase (ERK)2 activation. It has also been shown that ectopic expression of cFMS, a platelet-derived growth factor (PDGF)-family transmembrane tyrosine kinase receptor, enhances retinoic acid-induced differentiation and G1/0 arrest. The mechanism of how the retinoic acid and cFMS signaling pathways intersect is not known. The present data show that the ectopic expression of cFMS results in the differential loss of sensitivity of retinoic acid-induced differentiation or G1/0 arrest to inhibition of ERK2 activation. PD98059 was used to inhibit MEK and consequently ERK2. In wild-type HL-60 cells, PD98059 blocked retinoic acid-induced differentiation; but in cFMS stable transfectants, PD98059 only attenuated the induced differentiation, with the resulting response resembling that of retinoic acid-treated wild-type HL-60. In wild-type HL-60, PD98059 greatly attenuated the retinoic acid-induced G1/0 arrest allied with retinoblastoma (RB) hypophosphorylation; but in cFMS stable transfectants, PD98059 had no inhibitory effect on RB hypophosphorylation and G1/0 arrest. This differential sensitivity to PD98059 and uncoupling of retinoic acid-induced differentiation and G1/0 arrest in cFMS transfectants is associated with changes in mitogen-activated protein kinase signaling molecules. The cFMS transfectants had more activated ERK2 than did the wild-type cells, which surprisingly was not attributable to enhanced mitogen-activated protein-kinase-kinase-kinase (RAF) phosphorylation. Retinoic acid increased the amount of activated ERK2 and phosphorylated RAF in both cell lines. But PD98059 eliminated detectable ERK2 activation, as well as inhibited RAF phosphorylation, in untreated and retinoic acid-treated wild-type HL-60 and cFMS transfectants, consistent with MEK or ERK feedback-regulation of RAF, in all four cases. Since PD98059 blocks the cFMS-conferred enhancement of the retinoic acid-induced differentiation, but not growth arrest, the data indicate that cFMS-enhanced differentiation acts primarily through MEK and ERK2, but cFMS-enhanced G1/0 arrest allied with RB hypophosphorylation depends on another cFMS signal route, which by itself can effect G1/0 arrest without activated ERK2. Ectopic expression of cFMS and differential sensitivity to ERK2 inhibition thus reveal that retinoic acid-induced HL-60 cell differentiation and G1/0 arrest are differentially dependent on ERK2 and can be uncoupled. A significant unanticipated finding was that retinoic acid caused a MEK-dependent increase in the amount of phosphorylated RAF. This increase may help sustain prolonged ERK2 activation.
Similar content being viewed by others
References
Breitman, T. R.; Selonick, S. E.; Collins, S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Nat. Acad. Sci. USA 77:2936; 1980.
Brooks III S. C.; Kazmer, S.; Levin, A. A.; Yen, A. Myeloid differentiation and RB phosphorylation changes in HL-60 cells induced by RAR-and RXR-selective retinoic acid analogs. Blood 87:227–237; 1996.
Brown, G.; Bunce, C. M.; Rowlands, D. C.; Williams, G. R. All-trans retinoic acid and 1α,25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL-60 to monocytes. Leukemia 8:806–815; 1994.
Cai, H.; Erhardt, P.; Troppmair, J.; Diaz-Meco, M. T.; Sithanandam, G.; Rapp, U. R.; Moscat, J.; Cooper, G. M. Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase, during mitogenic signal transduction. Mol. Cell. Biol. 13:7645–7651; 1993.
Collins, S. J.; Gallo, R. C.; Gallagher, R. E. Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature 270:347; 1977.
Cooper, G. M. Pathways of mitogenic signal transduction. In: Oncogenes, 2nd ed. Boston and London: Jones and Barlett Publishers; 1995:279–306.
Fisher, T. L.; Blenis, J. Evidence for two catalytically active kinase domains in pp90-rsk. Mol. Cell. Biol. 16:1212–1219; 1996.
Fowles, L. F.; Martin, M. L.; Nelsen, L. et al. Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor1/c-fms signaling. Mol. Cell. Biol. 18:5148–5156; 1998.
Ghosh, A.; Kolodkin, A. L. Specification of neuronal connectivity: ETS marks the spot. Cell 95:303–306; 1998.
Kharbanda, S.; Salcem, A.; Hirano, M.; Emoto, Y.; Sukhatme, V.; Blenis, J.; Kufe, D. Activation of early growth response. 1. Gene transcription and pp90-rsk during induction of monocytic differentiation. Cell Growth Differ. 5:259–265; 1994.
Koay, D. C.; Sartorelli, A. C. Functional differentiation signals mediated by distinct regions of the cytoplasmic domain of the granulocyte colonystimulating factor receptor. Blood 93:3774–3784; 1999.
Lahayc, D. H. T. P.; Camps, M. G. M.; Van Erp, P. E.; Peters, P. H. J.; Van Zoelen, E. J. J. Epidermal growth factor (EGF) receptor density controls mitogenic activation of normal rat kidney (NRK) cells by EGF. J. Cell. Physiol. 174:9–17; 1998.
Lee, R.-M.; Cobb, M. H.; Blackshear, P. J. Evidence that extracellular signal-regulated kinases are the insulin-activated Raf-1 kinase kinases. J. Biol. Chem. 267:1088–1092; 1992.
Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase, activation. Cell 80:179–185; 1995.
Meyer, A. M. S.; Brenic, S.; Glaser, K. B. Pharmacological targeting of signaling pathways in protein kinase C-stimulated superoxide generation in neutrophil-like HL-60 cells: effect of phorbol ester, arachidonic acid and inhibitors of kinase(s), phosphatases(s) and phospholipase A-2. J. Pharm. Exp. Ther. 279;633–644; 1996.
Mihara, K.; Cao, X. R.; Yen, A.; Chandler, S.; Driscoll, B.; Murphree, A. L.; T'Ang, A.; Fung, Y. K. T. Cell-cycle dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246: 1300–1303; 1989.
Morrison, D. K.; Heidecker, G.; Rapp, U. R.; Copeland, T. R. Identification of the major phosphorylation sites of the Raf-1 kinase. J. Biol. Chem. 268:17,309–17,316; 1993.
Platko, J. D.; Forbes, M. E.; Varvayanis, S.; Williams, M. N.; Brooks III, S. C.; Cherington, V.; Yen, A. Polyoma middle T antigen in HL-60 cells accelerates hematopoietic myeloid and monocytic cell differentiation. Exp. Cell Res. 238:42–50; 1998.
Quesenberry, P. J. Hemopoietic stem cells, progenitor cells, and growth factors, In: Williams, W. J.; Beutler, E.; Erslev, A. J.; Lichtman, M. A., ed. Hematology. 4th ed. New York: McGraw-Hill; 1980:129.
Sherr, C. J. The colony-stimulating factor 1 receptors: pleiotrophy of signalresponse coupling. Lymphokine Res. 9:543–548; 1990.
Traverse, S.; Gomez, N.; Paterson, H.; Marshall, C.; Cohen, P. Sustained activation of the mitogen-activated protein MAP kinase cascade may be required for differentiation of PC12 cells: comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288: 352–355; 1992.
Yen, A. HL-60 cells as a model of growth control and differentiation: the significance of variant cells. Hematol. Rev. 4:5–46; 1990.
Yen, A.; Chandler, S. Inducers of leukemic cell differentiation cause down-Tregulation of RB gene expression. Proc. Soc. Exp. Biol. Med. 199: 291–297; 1992.
Yen, A.; Chandler, S.; Forbes, M. E.; Fung, Y. K.; T'Ang, A.; Pearson, R. C. Coupled down-regulation of the RB retinoblastoma and c-myc genes antecedes cell differentiation: possible role of RB as a “Status Quo” gene. Eur. J. Cell. Biol. 57:210–221; 1992.
Yen, A.; Cherington, V.; Schaffhausen, B., Marks, K.; Varvayanis, S. Transformation defective polyoma middle-T antigen mutants defective in PLCγ, PI-3 or SRC kinase activation enhance ERK2 activation and promote retinoic acid induced cell differentiation like wild-type middle-T. Exp. Cell Res. 248:538–551; 1999.
Yen, A.; Forbes, M. E. c-myc Down-regulation and precommitment in HL-R60 cells due to bromodeoxyuridine. Cancer Res. 50:1411–1420; 1990.
Yen, A.; Forbes, M.; deGala, G.; Fishbaugh, J. Control of HL-60 cell differentiation lineage specificity: a late event occurring after precommitment. Cancer Res. 47:129–134; 1987.
Yen, A.; Forbes, M. E.; Varvayanis, S.; Tykocinski, M. L.; Groger, R. K.; Platko, J. D. c-FMS dependent HL-60 cell differentiation and regulation of RB expression. J. Cell. Physiol. 157379–391; 1993.
Yen, A.; Reece, S. L.; Albright, K. L. Dependence of HL-60 myeloid cell differentiation on continous and split retinoic acid exposures: precommitment memory associated with altered nuclear structure. J. Cell. Physiol. 118:277–286; 1984.
Yen, R.; Roberson, M. C.; Varvayanis, S.; Lee, A. T. Retinoic acid induced mitogen-activated protein (MAP)/extracelular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 58:3163–3172; 1998.
Yen, A.; Sturgill, R. Hypophosphorylation of the RB protein in S and G2 as well as G1 during growth arrest. Exp. Cell Res. 241:324–331; 1998.
Yen, A.; Sturgill, R.; Varvayanis, S. Inercasing c-FMS expression decreases retinoic acid concentration needed to cause cell differentiation and RB hypophosphorylation. Cancer Res. 57:2020–2028; 1997.
Yen, A.; Sturgill, R.; Varvayanis, S.; Chern, R. FMS (CSF-1 receptor) prolongs cell cycle, promotes retinoic acid induced hypophosphorylation of RB protein, G1 arrest and cell differentiation. Exp. Cell Res. 229:111–125; 1996.
Zimmermann, S.; Rommel, C. Ziogas, A.; Lovric, J.; Moelling, K.; Radziwill, G. MEK1 mediates a positive feedback on Raf-1 activity independently of Ras and Src. Oncogene 15:1503–1511; 1997.
Zhu, W. Y.; Jones, C. S.; Amin, S.; Matsukuma, K.; Haque, M.; Vuligonda, V.; Chandraratna, R. A. S.; DeLuca, L. M. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells. Cancer Res. 59:85–90; 1999.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yen, A., Sturgill, R. & Varvayanis, S. Retinoic acid increases amount of phosphorylated raf; Ectopic expression of cFMS reveals that retinoic acid-induced differentiation is more strongly dependent on ERK2 signaling than induced go arrest is. In Vitro Cell.Dev.Biol.-Animal 36, 249–255 (2000). https://doi.org/10.1290/1071-2690(2000)036<0249:RAIAOP>2.0.CO;2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1290/1071-2690(2000)036<0249:RAIAOP>2.0.CO;2